United Health Products, Inc. (UEEC)
| Market Cap | 68.15M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -2.00M |
| Shares Out | 252.41M |
| EPS (ttm) | -0.01 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 12,000 |
| Average Volume | 81,980 |
| Open | 0.2600 |
| Previous Close | 0.2700 |
| Day's Range | 0.2600 - 0.2700 |
| 52-Week Range | 0.0460 - 0.2850 |
| Beta | -1.25 |
| RSI | 63.06 |
| Earnings Date | Mar 28, 2025 |
About United Health Products
United Health Products, Inc. develops, manufactures, and markets hemostatic gauze products for the healthcare and wound care sectors in the United States. The company offers CelluSTAT hemostatic gauze products to absorb exudate/drainage from superficial wounds, as well as helps in controlling bleeding. It serves hospitals and surgery centers, clinics and physicians, military medical care providers, hemodialysis centers, nursing homes and assisted living, and veterinary hospitals; and EMS, fire departments, and other first responders, as well as... [Read more]
Financial Performance
Financial StatementsNews
United Health Products Provides Update on Clinical Study Process
MT. LAUREL, N.J., Dec. 02, 2024 (GLOBE NEWSWIRE) -- United Health Products, Inc. (OTCPK: UEEC) today provided an update on the company's planned clinical study.
United Health Products Submits Response Letter to FDA
MT. LAUREL, NJ, Aug. 19, 2024 (GLOBE NEWSWIRE) -- United Health Products, Inc. (OTCPK: UEEC) today provided an update on the company's FDA Premarket Approval (PMA) application process.
United Health Products Submits Full FDA PMA Application
MOUNT LAUREL, NJ, March 21, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -- United Health Products, Inc. (OTCPK: UEEC) today provided an update on the company's FDA Premarket Approval application process...
United Health Products Reports on FDA Application Status
MESQUITE, NV, Jan. 19, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – United Health Products (UEEC) reports today on the receipt and review of final reports on product sterilization and stability testing...
The Medicare Gold Rush Is Slowing Down
UnitedHealth's disappointing outlook and the Humana sale talks intensify concerns that the Medicare Advantage business isn't what it once was.
United Health Products Reports on Product Testing for FDA Application
MESQUITE, NV, Aug. 04, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – United Health Products, Inc. (OTCPK: UEEC) today provided an update on the company's FDA Premarket Approval application process.
United Health Products Reports on Progress in Product Testing
MESQUITE, NV, June 27, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – United Health Products, Inc. (OTCPK: UEEC) today provided an update on the company's FDA Premarket Approval application process.
United Health Products Reiterates Guidance on FDA PMA Application Process
MESQUITE, NV, June 07, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – United Health Products, Inc. (OTCPK: UEEC) today provided an update on the company's FDA Premarket Approval application process.
Dow Stocks To Trade In June
This long/short strategy is producing profitable results. Here is what to do now.
United Health Products Provides Update on FDA PMA Application Process
Mesquite, NV, March 29, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – United Health Products, Inc. (OTCPK: UEEC) today provided an update on the company's FDA Premarket Approval application process.
United Health Products Provides Update on FDA PMA Application and Amendment to White Lion Agreement
Mesquite, NV, Jan. 31, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- United Health Products, Inc. (OTCPK: UEEC), (UHP) today provided an update on the company's FDA Premarket Approval application pr...
United Health Products Provides Update on Manufacturing and FDA PMA Application
MESQUITE, NV, Dec. 19, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – United Health Products, Inc. (OTCPK: UEEC), (UHP) today provided an update on the company's FDA Premarket Approval application.
United Health Products Provides Update on FDA PMA Application
Mesquite, NV, Nov. 28, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- United Health Products, Inc. (OTCPK: UEEC), (UHP) today provides an update on the company's FDA Premarket Approval application.
CNBC Stock World Cup: United Healthcare vs Johnson & Johnson and Netflix vs Disney — who wins?
Heading into the World Cup season, CNBC spoke to Chuck Lieberman of Advisors Capital Management on whether United Healthcare or Johnson & Johnson will give investors a greater total return over the ne...
United Health Products Announces Equity Financing Agreement and Provides Corporate Update
Mesquite, NV, Sept. 06, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- United Health Products, Inc. (OTCPK: UEEC), (UHP) today announced that it has entered into a common stock purchase agreement to sel...
United Health Products Announces Settlement of SEC Investigation
HENDERSON, NV, June 16, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – United Health Products, Inc. (OTCPK: UEEC) (UHP), today announced a final settlement of the SEC investigation initially reported by ...
United Health Products Provides Regulatory Update
Henderson, NV, May 18, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- United Health Products, Inc. (OTCPK: UEEC), (UHP) today provided an update on its FDA regulatory process.
United Health Products Provides Regulatory and Business Update
Henderson, NV, April 27, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- United Health Products, Inc. (OTCPK: UEEC), (UHP) today provided an update on its FDA regulatory process and other matters.
Stocks To Trade In December
Here are the long-short recommendations for this month.
United Health Products Provides Corporate Update and Announces Equity Financing
HENDERSON, NV / ACCESSWIRE / June 28, 2021 / United Health Products, Inc. (OTCPK:UEEC), ('UHP'), developer, manufacturer and marketer of HemoStyp, a patented Neutralized Oxidized Regenerated Cellulose...
United Health Products' HemoStyp® Gauze Advances to FDA Substantive Review
HENDERSON, Nev.--(BUSINESS WIRE)--United Health Products, Inc. (OTCPK: UEEC), (“UHP” or the “Company”), developer, manufacturer and marketer of HemoStyp®, a patented Neutralized Oxidized Regenerated C...
United Health Products Obtains International Patent Protection Measures for HemoStyp® Hydrocolloid
HENDERSON, Nev.--(BUSINESS WIRE)--United Health Products, Inc. (OTC: UEEC), (“UHP” or the “Company”), developer of HemoStyp, a patented Neutralized Oxidized Regenerated Cellulose (NORC) hemostatic age...
United Health Products Announces Leadership Changes
HENDERSON, Nev,--(BUSINESS WIRE)--United Health Products, Inc. (OTC: UEEC), (“UHP” or the "company”), developer, manufacturer and marketer of HemoStyp®, a patented Neutralized Oxidized Regenerated Cel...
United Health Products Announces Journal of Wound Care to Publish HemoStyp® Human Trial Peer Reviewed Article
HENDERSON, Nev.--(BUSINESS WIRE)--United Health Products, Inc. (OTC: UEEC) (“UHP” or the “Company”), developer, manufacturer and marketer of HemoStyp, a patented Oxidized Regenerated Cellulose (ORC), ...